Volitionrx Ltd (VNRX) Stock Analysis

Volitionrx Ltd (VNRX) is a publicly traded company in the HEALTHCARE sector. It trades at $2.33, carries a market capitalization of $22.08M. This page summarizes the public market data, fundamentals, and frequently asked questions for VNRX, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - MEDICAL DEVICES

Exchange: NYSE MKT

Key Metrics

• Price: $2.33
• Market Cap: $22.08M
• EPS: $-4.25
• 52-Week High: $18.80
• 52-Week Low: $1.91

Market Sentiment

Volitionrx Ltd currently has a Bullish sentiment score of 0.31.

About Volitionrx Ltd

VolitionRx Limited (VNRX) is an innovative multinational epigenetics company based in Austin, Texas, dedicated to developing blood-based diagnostic tests aimed at improving cancer detection and other disease diagnoses globally. Utilizing its proprietary Nu.Q™ platform, VolitionRx focuses on creating advanced, non-invasive diagnostic solutions that seek to enhance patient outcomes through early disease detection. Positioned at the cutting edge of the expanding epigenetics market, the company i...

GNG Research Analysis

GNG Research scores Volitionrx Ltd (VNRX) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for VNRX.

Frequently Asked Questions

Does VNRX pay dividends?

Volitionrx Ltd (VNRX) does not currently pay a regular dividend.

What is VNRX's market cap?

Volitionrx Ltd (VNRX) has a market capitalization of $22.08M with a current stock price of $2.33.